During this segment, the panelists share their final insights about the future of immunotherapy. Jeffrey Weber, MD, PhD, believes that treating patients with immunotherapy will benefit all parties ...

“As the next part is the conclusion, I gave Nomura the homework that I want something that would respect the original, while also giving a sense of satisfaction beyond what could be experienced in the ...